{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-21-053303","form_type":"8-K","ticker":"TARA","cik":"0001359931","company_name":"Protara Therapeutics, Inc.","filed_at":"2021-10-18T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.241461+00:00","generated_at":"2026-06-28T20:14:18.386639+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Protara Therapeutics CMO Departs; Jathin Bandari Named Interim CMO","bullets":["Martín Sebastian Olivo, M.D., left as Chief Medical Officer effective Oct 15, 2021; will serve as consultant through Nov 22, 2021.","Jathin Bandari, M.D., promoted to VP, Head of Clinical Development and Interim Chief Medical Officer.","Severance includes nine months base salary lump sum, pro-rata bonus, COBRA reimbursement, and pro-rata equity vesting.","Dr. Bandari joined Protara in April 2020; is a urologic oncologist with fellowship at University of Pittsburgh Medical Center."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-21-053303","json":"https://secwatch.observer/filing/0001213900-21-053303.json","markdown":"https://secwatch.observer/filing/0001213900-21-053303.md","text":"https://secwatch.observer/filing/0001213900-21-053303.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1359931/000121390021053303/0001213900-21-053303-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1359931/000121390021053303/ea149033-8k_protarathera.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T20:14:18.386639+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a7294125d3","claim":"Martín Sebastian Olivo departed as Chief Medical Officer at Protara Therapeutics, Inc..","evidence_excerpt":"Effective October 15, 2021, Martín Sebastian Olivo, M.D. will no longer be employed by the Company as Chief Medical Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390021053303/0001213900-21-053303-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will no longer be employed"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}